← Leaderboards
Steven J Siegel
University Of Pennsylvania
$10,032,755
Attributed
$14,212,408
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,212,408 · 6
By mechanism
R01$6,290,852 · 3
KL2$6,275,474 · 1
P50$1,329,082 · 1
R21$317,000 · 1
Top collaborators
- Chang-Gyu Hahn6 shared
- Cecilia Maria Patino Sutton6 shared
- Karin Borgmann-Winter1 shared
- Elizabeth Rhea Erwin Burner1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Emma Anne Meagher$18,498,182
- E Michael Ostap$23,710,653
- John Patterson Atkinson$19,338,397
- Glen N Gaulton$23,495,239
- Avinash Bhandoola$7,204,020
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseBehaviorBrainPharmaceutical PreparationsPatternSignal TransductionBehavioralIn VivoSchizophreniaHippocampus (Brain)N-Methyl-D-Aspartate ReceptorsSymptomsChronicFundingReceptor SignalingNeuronsRisperidoneReceptorMediatingProgramsAffinityReceptor FunctionLeadInjection Of Therapeutic Agent
Grant awards (33)
Institutional Career Development Core$911,750
KL2 · FY2024 · TR
Institutional Career Development Core$911,750
KL2 · FY2023 · TR
Institutional Career Development Core$913,750
KL2 · FY2022 · TR
Mentored Career Development$884,217
KL2 · FY2020 · TR · contact PI
Mentored Career Development$884,669
KL2 · FY2019 · TR · contact PI
Src hypoactivity as a mediator of various molecular alterations leading to NMDAR$214,870
R01 · FY2019 · MH
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$166,343
R01 · FY2019 · MH
Mentored Career Development$884,669
KL2 · FY2018 · TR · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$388,341
R01 · FY2018 · MH
Mentored Career Development$884,669
KL2 · FY2017 · TR · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$389,781
R01 · FY2017 · MH
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$389,781
R01 · FY2016 · MH
Electrophysiological Markers of Social Function$258,858
P50 · FY2016 · MH · contact PI
Src mediates molecular alterations leading to NMDAR hypofunction in schizophrenia$463,092
R01 · FY2015 · MH
Electrophysiological Markers of Social Function$261,680
P50 · FY2015 · MH · contact PI
An Implantable Semiannual Antipsychotic Delivery System$390,048
R01 · FY2014 · MH · contact PI
Electrophysiological Markers of Social Function$257,597
P50 · FY2014 · MH · contact PI
Electrophysiological Markers of Social Function$1
P50 · FY2014 · MH · contact PI
An Implantable Semiannual Antipsychotic Delivery System$374,446
R01 · FY2013 · MH · contact PI
Electrophysiological Markers of Social Function$273,766
P50 · FY2013 · MH · contact PI
An Implantable Semiannual Antipsychotic Delivery System$390,048
R01 · FY2012 · MH · contact PI
Long-term neurobehavioral effects of ketamine exposure in adolescent mice$378,118
R01 · FY2012 · DA · contact PI
Electrophysiological Markers of Social Function$277,180
P50 · FY2012 · MH · contact PI
An Implantable Semiannual Antipsychotic Delivery System$390,048
R01 · FY2011 · MH · contact PI
Long-term neurobehavioral effects of ketamine exposure in adolescent mice$378,118
R01 · FY2011 · DA · contact PI
An Implantable Semiannual Antipsychotic Delivery System$392,588
R01 · FY2010 · MH · contact PI
Long-term neurobehavioral effects of ketamine exposure in adolescent mice$389,813
R01 · FY2010 · DA · contact PI
Long-term neurobehavioral effects of ketamine exposure in adolescent mice$393,750
R01 · FY2009 · DA · contact PI
Long-term neurobehavioral effects of ketamine exposure in adolescent mice$393,750
R01 · FY2008 · DA · contact PI
An implantable semiannual antipsychotic delivery system$210,263
R01 · FY2008 · MH · contact PI
An implantable semiannual antipsychotic delivery system$197,654
R01 · FY2007 · MH · contact PI
Evoked potentials and vulnerability to ketamine in mice.$158,500
R21 · FY2004 · DA
Evoked potentials and vulnerability to ketamine in mice.$158,500
R21 · FY2003 · DA